Complement and Bacterial Infections: From Molecular Mechanisms to Therapeutic Applications

Publication date

2018-12-01

Authors

Heesterbeek, Dani A.C.
Angelier, Mathieu L.
Harrison, Richard A.
Rooijakkers, Suzan H MORCID 0000-0003-4102-0377ISNI 0000000396157098

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by_nc_nd

Abstract

Complement is a complex protein network of plasma, and an integral part of the innate immune system. Complement activation results in the rapid clearance of bacteria by immune cells, and direct bacterial killing via large pore-forming complexes. Here we review important recent discoveries in the complement field, focusing on interactions relevant for the defense against bacteria. Understanding the molecular interplay between complement and bacteria is of great importance for future therapies for infectious and inflammatory diseases. Antibodies that support complement-dependent bacterial killing are of interest for the development of alternative therapies to treat infections with antibiotic-resistant bacteria. Furthermore, a variety of novel therapeutic complement inhibitors have been developed to prevent unwanted complement activation in autoimmune inflammatory diseases. A better understanding of how such inhibitors may increase the risk of bacterial infections is essential if such therapies are to be successful.

Keywords

Antibiotic resistance, Antibody therapy, Bacteria, Complement, Eculizumab, Infections, Inflammatory diseases, Membrane attack complex, Neisseria, Immunology and Allergy

Citation

Heesterbeek, D A C, Angelier, M L, Harrison, R A & Rooijakkers, S H M 2018, 'Complement and Bacterial Infections : From Molecular Mechanisms to Therapeutic Applications', Journal of Innate Immunity, vol. 10, no. 5-6, pp. 455-464. https://doi.org/10.1159/000491439